Ophthalmic Handheld Devices Market Analysis

Ophthalmic Handheld Devices Market Analysis

To get key market trends

  Download Free Sample

The market by product type is segmented into ophthalmoscopes, retinoscopes, tonometers, pachymeters, autorefractors, slit lamp biomicroscopes, handheld fundus cameras, and other product types. The ophthalmoscopes segment is further divided into direct ophthalmoscopes, and indirect ophthalmoscopes. This segment accounted for significant revenue share and was valued at around USD 86.1 million in 2023.
 

• The increasing prevalence of eye diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma necessitates regular eye examinations. Ophthalmoscopes are vital for the early detection and monitoring of these conditions, hence, driving their demand.
   
• As per the article published by NCBI, the number of diabetic retinopathy individuals in the U.S. is expected to rise to 16.0 million by 2050, with 3.4 million of them suffering from vision-threatening issues.
   
• Moreover, technological advancements have led to the development of advanced ophthalmoscopes with features like digital imaging, enhanced optics, and integration with electronic health record (EHR) systems. These innovations improve diagnostic accuracy and contribute to the overall efficiency of eye examinations.
   

Based on category, the ophthalmic handheld devices market is divided into traditional handheld devices, and digital/smart handheld devices. The digital/smart handheld devices segment is anticipated to witness higher growth with a CAGR of 3.1% throughout the forecast period.
 

• Advanced imaging features including digital sensors and high-resolution cameras often appear in ophthalmology's digital and smart portable devices. These characteristics enable thorough and exact imaging of the eye structures, assisting in accurate identification and monitoring of eye disorders.
   
• Moreover, the rise of teleophthalmology and the need for remote patient monitoring have driven the demand for digital/smart handheld devices. These devices enable healthcare professionals to conduct remote eye examinations, share images securely, and monitor patients' eye health from a distance, facilitating broader access to eye care services.
   

Based on application, the market is categorized into vitreo retinal disorders, glaucoma, cataract, refractor disorders and other applications. The vitreo retinal disorders segment held a share of 14% in the global ophthalmic handheld devices market, in 2023.
 

• Vitreo-retinal disorders often require early detection and timely intervention to prevent irreversible vision loss. Ophthalmic handheld devices play a crucial role in facilitating early diagnosis through detailed examination of the retina, allowing for prompt treatment and management.
   
• Additionally, portable and handheld OCT devices are particularly important in vitreo-retinal care. These devices provide real-time, cross-sectional imaging of the retina, allowing ophthalmologists to visualize the layers of the retina and diagnose conditions such as macular edema and epiretinal membranes.
   

The market by end-use is categorized into hospitals & eye clinics, ambulatory surgical centers, and other end-users. The hospitals & eye clinics segment was valued at USD 369 million in 2023.
 

• Hospitals and eye clinics often experience a high patient flow, necessitating efficient and time-sensitive diagnostic tools. Ophthalmic handheld devices offer the advantage of portability and ease of use, allowing healthcare professionals to conduct quick eye examinations, making them well-suited for busy clinical environments.
   
• Furthermore, point-of-care diagnostics are growing increasingly popular in hospitals and eye clinics, where rapid diagnoses are essential. Handheld devices enable ophthalmologists and optometrists to do on-the-spot examinations, allowing for faster diagnosis and treatment of eye diseases.
   

North America ophthalmic handheld devices market was valued at USD 204.5 million in 2023 and is predicted to witness a market growth of 2.2% over the analysis timeline.
 

• North America has one of the highest healthcare expenditures globally. The willingness to invest in advanced medical technologies, including ophthalmic handheld devices, contributes to the growth of the market. Well-established healthcare infrastructure further supports the adoption of these devices. Moreover, the region has a significant target population base for various eye related disorders, thus, fueling the regional growth.
   
• Furthermore, there is a growing focus on preventive healthcare in the region, including routine eye examinations. Ophthalmic handheld devices play a crucial role in early detection and preventive care, aligning with the broader healthcare trends in the region.